Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

Larry R. Helms

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 11 Aug, 2022
"Edit from table cell"
Дмитрий Лукьянов profile picture
Дмитрий Лукьянов
edited on 11 Aug, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Company Operating Status
Active
Edits on 27 Jul, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Jul, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Competitors
‌
PLA
Edits on 29 Apr, 2022
Charles Thompson profile picture
Charles Thompson
edited on 29 Apr, 2022
Edits made to:
Infobox (+1 properties)
Infobox
LinkedIn
https://www.linkedin.com/in/larry-helms-0a2bb86
Edits on 14 Dec, 2021
"Remove inverse infobox"
Golden AI profile picture
Golden AI
edited on 14 Dec, 2021
Edits made to:
Infobox (-367 properties)
Infobox
Patent primary examiner of
‌
US Patent 7087718 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
‌
US Patent 7090844 Use of antibodies against the MUC18 antigen
‌
US Patent 7094868 Peptides for recognition and targeting of GLIAL cell tumors
‌
US Patent 7097840 Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
‌
US Patent 7097989 Complement C3 precursor biopolymer markers predictive of type II diabetes
‌
US Patent 7098006 Chimeric antibody, pharmaceutical composition and process of its production
‌
US Patent 7108983 Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker
‌
US Patent 7112324 CD 19×CD3 specific polypeptides and uses thereof
‌
US Patent 7112656 PRO1312 polypeptides
‌
US Patent 7115715 Anti-idiotype antibodies to MN proteins and MN polypeptides
‌
US Patent 7115716 Tumor specific monoclonal antibodies
‌
US Patent 7118745 Engineering antibodies that bind irreversibly
‌
US Patent 7118889 Protein tyrosine kinase substrate LAT and its use in the indentification of (ant)agonists of the kinase
‌
US Patent 7122646 Multivalent and multispecific binding proteins, their manufacture and use
‌
US Patent 7128894 Contrast enhancing solution for use in confocal microscopy
‌
US Patent 7129330 Multivalent antibody constructs
‌
US Patent 7129332 Anti-EGFRvIII scFvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereof
‌
US Patent 7132510 Specific human antibodies for selective cancer therapy
‌
US Patent 7132511 Modified anti-EGFR antibodies with reduced immunogenicity
‌
US Patent 7135555 Mammalian TNF-α convertases
‌
US Patent 7147855 GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
‌
US Patent 7148016 Immunoassays to detect diseases or disease susceptibility traits
‌
US Patent 7148321 Expression technology for proteins containing a hybrid isotype antibody moiety
‌
US Patent 7148326 Tumor antigen
‌
US Patent 7148337 C-type LECTIN transmembrane antigen expressed in human prostate cancer and uses thereof
‌
US Patent 7151169 Specific binding members for TGFβ
‌
US Patent 7153940 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
‌
US Patent 7166286 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for prophylaxis and detection of cancers
‌
US Patent 7166691 Saposin C and receptors as targets for treatment of benign and malignant disorders
‌
US Patent 7166694 Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells
‌
US Patent 7175981 Method of diagnosing stage or aggressiveness of breast and prostate cancer based on levels of fatty acid binding proteins
‌
US Patent 7175996 Methods of optimizing antibody variable region binding affinity
‌
US Patent 7179595 Compositions and methods for generating antigen-binding units
‌
US Patent 7179609 Screening method for gastritis
‌
US Patent 7179891 Physiologically active complex
‌
US Patent 7183051 Diagnosis and treatment of cancer
‌
US Patent 7189816 Compounds
‌
US Patent 7198920 HER-2/neu fusion proteins
‌
US Patent 7211397 Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection
‌
US Patent 7211646 Chondrosarcoma associated genes
‌
US Patent 7229623 Her-2/neu fusion proteins
‌
US Patent 7232891 Anti-human luteinizing hormone-related antibodies and uses thereof
‌
US Patent 7235380 CDR-grafted anti-tissue factor antibodies and methods of use thereof
‌
US Patent 7238524 Prostate cancer cell lines
‌
US Patent 7238786 Monoclonal antibody cPAM4
‌
US Patent 7247703 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
‌
US Patent 7252824 Anti-neovasculature preparations for cancer
‌
US Patent 7253263 Complementarity determining region-grafted antibody against ganglioside GD3 and derivative of antibody against ganglioside GD3
‌
US Patent 7256004 Variants of humanized anti-carcinoma monoclonal antibody CC49
‌
US Patent 7258987 Methods of cytodiagnostic staging of neoplasia and squamous cell carcinoma
‌
US Patent 7259236 RBP1L1, a novel retinoblastoma binding protein-related gene encoding an antigenic epitope and methods of using thereof
‌
US Patent 7261892 Methods for diagnosis and treatment of epithelial-derived cancers
‌
US Patent 7262028 Recombinant production of mixtures of antibodies
‌
US Patent 7262277 Antagonistic anti-hFAS ligand human antibodies and fragments thereof
‌
US Patent 7264806 Modified anti-CD52 antibody
‌
US Patent 7265216 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
‌
US Patent 7267821 Binding member which binds to both Lewis
‌
US Patent 7268218 Cardiovascular system associated protein kinase 3 (CSAPK-3) antibodies
‌
US Patent 7270819 Isolated nucleic acid molecules encoding isolated peptides which correspond to contiguous amino acids of an SSX molecule or NY-ESO-1 and uses thereof
‌
US Patent 7273610 Endotheliase-2 ligands
‌
US Patent 7276331 Plus end-directed microtubule motor required for chromosome congression
‌
US Patent 7276589 Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis
‌
US Patent 7282567 Monoclonal antibody hPAM4
‌
US Patent 7285268 Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis
‌
US Patent 7291335 Isolated nucleic acid molecules encoding ESO-1 peptides and uses thereof
‌
US Patent 7300655 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
‌
US Patent 7311914 MAGE-A4 antigenic peptides and uses thereof
‌
US Patent 7314622 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
‌
US Patent 7323304 Method for the immunocytological or molecular detection of disseminated tumor cells from a body fluid and kit that is suitable therefor
‌
US Patent 7326414 Antibodies to M-CSF
‌
US Patent 7329497 Gene causative of Rothmund-Thomson syndrome and its gene product
‌
US Patent 7329744 Fusion genes associated with acute megakaryoblastoc leukemias
‌
US Patent 7332585 Bispecific single chain Fv antibody molecules and methods of use thereof
‌
US Patent 7335747 Cancer associated gene mina 53, protein Mina 53 and monoclonal antibody thereof
‌
US Patent 7341722 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment
‌
US Patent 7341730 Inhibitors of angiogenesis and tumor growth
‌
US Patent 7341994 GD3-mimetic peptides
‌
US Patent 7342099 cDNA encoding a gene BOG (B5T over-expressed gene) and its protein product
‌
US Patent 7348007 Mage C2 antigenic peptides and uses thereof
‌
US Patent 7348153 Method for identifying and designing immunogenic peptides
‌
US Patent 7348413 Cancerous disease modifying antibodies
‌
US Patent 7351694 Human NK-3 related prostate specific gene-1
‌
US Patent 7358046 Sensitivity test to predict efficacy of anti-cancer therapies
‌
US Patent 7361360 Method of treating cancer cells to create a modified cancer cell that provokes an immunogenic response
‌
US Patent 7364862 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
‌
US Patent 7371381 Anti-galanin antibodies and uses thereof
‌
US Patent 7371818 Polypeptide and DNA thereof
‌
US Patent 7371835 p53-dependent apoptosis-inducing protein and method of screening for apoptosis regulator
‌
US Patent 7374909 Modulators of intracellular inflammation, cell death and cell survival pathways
‌
US Patent 7375091 HER-2/neu fusion proteins
‌
US Patent 7375206 Brother of the regulator of imprinted sites (BORIS)
‌
US Patent 7378386 Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives
‌
US Patent 7390625 Apoptosis-associated protein and use thereof
‌
US Patent 7390670 Signalling compounds and methods for detecting hydrogen peroxide
‌
US Patent 7393637 Methods for detecting cancer and monitoring cancer progression
‌
US Patent 7393921 Prostate-specific polypeptide pamp and encoding nucleic acid molecules
‌
US Patent 7396917 Rationally designed antibodies
‌
US Patent 7399827 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
‌
US Patent 7399835 Cancerous disease modifying antibodies
‌
US Patent 7399849 Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof
‌
US Patent 7404963 Flagellin-based adjuvants and vaccines
‌
US Patent 7411045 Autocrine growth factor receptor antibodies and methods
‌
US Patent 7411046 Cancerous disease modifying antibodies
‌
US Patent 7413894 TAG-1 and TAG-2 proteins and uses thereof
‌
US Patent 7413899 Genes from the 20q13 amplicon and their uses
‌
US Patent 7416725 Compositions and methods of using galectin-8 as an inhibitor of tumor cell growth
‌
US Patent 7417127 Antibodies specific for CD44v6
‌
US Patent 7419669 Peptide epitopes common to antigens of the same multigene family
‌
US Patent 7419811 Use of specifically engineered enzymes to enhance the efficacy of prodrugs
‌
US Patent 7420045 IAPs associated cell cycle proteins, compositions and methods of use
‌
US Patent 7423115 ARTS C-terminus fragments and mimetics thereof
‌
US Patent 7425623 Antibody with specificity for colon cancer
‌
US Patent 7429380 Production of a multimeric protein by cell fusion method
‌
US Patent 7429457 Id-1 and Id-2 genes and products as markers of epithelial cancer
‌
US Patent 7432064 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
‌
US Patent 7432357 Anti-cancer antibodies with reduced complement fixation
‌
US Patent 7432358 Oncogene, recombinant protein derived therefrom, and uses thereof
‌
US Patent 7435806 Nucleic acid binding of multi-zinc finger transcription factors
‌
US Patent 7439032 Methods to identify compounds useful for tumor sensitization to DNA damage
‌
US Patent 7439223 Nucleophosmin/B23-binding peptide to inhibit tumor growth and regulate transcriptional activity of p53
‌
US Patent 7439319 Selective substrates for matrix metalloproteinases
‌
US Patent 7442776 Cancerous disease modifying antibodies
‌
US Patent 7445906 Method of detecting cancer using delta-catenin
‌
US Patent 7446176 12 human secreted proteins
‌
US Patent 7446178 Antibodies that recognize hyperproliferative cells and methods of making and using same
‌
US Patent 7449184 Fixed dosing of HER antibodies
‌
US Patent 7452965 Colon tumor specific binding peptides
‌
US Patent 7452967 Molecules of the card-related protein family and uses thereof
‌
US Patent 7452976 Biological products
‌
US Patent 7455833 Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids
‌
US Patent 7455964 Genes from the 20q13 amplicon and their uses
‌
US Patent 7459157 Detection of dysplastic or neoplastic cells using anti-MCM2 antibodies
‌
US Patent 7459282 Use of c-Jun or c-Jun activating agents such as UV or c-Jun N-terminal kinases (JNKs) for treating cancer
‌
US Patent 7465790 Therapeutic antibodies
‌
US Patent 7470514 Method of diagnosing, monitoring, and staging prostate cancer
‌
US Patent 7473531 Pancreatic cancer targets and uses thereof
‌
US Patent 7473534 Assays for cancer patient monitoring based on levels of epidermal growth factor receptor (EGFR) extracellular domain (ECD) analyte, alone or in combination with other analytes, in body fluid samples
‌
US Patent 7476719 Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof
‌
US Patent 7479537 Reagents and methods useful for detecting diseases of the breast
‌
US Patent 7479546 Pro104 antibody compositions and methods of use
‌
US Patent 7482435 Rationally designed antibodies
‌
US Patent 7485300 Cancerous disease modifying antibodies
‌
US Patent 7488792 Collagen-binding molecules that selectively home to tumor vasculature and methods of using same
‌
US Patent 7488806 Human antibodies to human delta like ligand 4
‌
US Patent 7491394 Cytotoxic factors for modulating cell death
‌
US Patent 7491802 Anti-BAMBI antibody and diagnostic or remedy for colon cancer and liver cancer
‌
US Patent 7494775 Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
‌
US Patent 7495086 TWEAK receptor
‌
US Patent 7498129 Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof
‌
US Patent 7498414 Human antibodies specific to KDR and uses thereof
‌
US Patent 7498420 Antibodies to c-Met
‌
US Patent 7504212 Cancer monitoring and therapeutics
‌
US Patent 7507788 Peptides and methods for cell death regulation
‌
US Patent 7507796 Multivalent antibody constructs
‌
US Patent 7521175 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
‌
US Patent 7521541 Cysteine engineered antibodies and conjugates
‌
US Patent 7521543 A34 and A33-like 3 DNA, proteins, antibodies thereto and methods of treatment using same
‌
US Patent 7527789 Use of a preparation based on an antibody directed against a tumor-associated glycosylation
‌
US Patent 7527969 RAAG10 cell surface target and a family of antibodies recognizing that target
‌
US Patent 7531624 Nuclear targeting sequence
‌
US Patent 7531634 Bladder matrix protein peptides and methods of detection of bladder cancer
‌
US Patent 7534565 DLC-1 gene deleted in cancers
‌
US Patent 7534861 Compositions and methods for immunoaffinity purification
‌
US Patent 7534868 Human antibodies to human delta like ligand 4
‌
US Patent 7537894 Methods and kits for monitoring Barrett's metaplasia
‌
US Patent 7541034 Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors
‌
US Patent 7541428 Tumor antigen protein SART-3 and tumor antigen peptides thereof
‌
US Patent 7544767 HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
‌
US Patent 7544775 Systems for expressing toxic proteins, vectors and method of producing toxic proteins
‌
US Patent 7547439 Tumor rejection antigens
‌
US Patent 7550256 Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
‌
US Patent 7557193 Glycopeptides derived from pancreatic structures, antibodies and applications thereof in diagnostics and therapeutics
‌
US Patent 7563570 Method of determining a chemotherapeutic regimen for non small cell lung cancer based on BRCA1 expression
‌
US Patent 7563870 LAGE-1 tumor associated nucleic acids
‌
US Patent 7566450 Humanized anti-CCR2 antibodies and methods of use therefor
‌
US Patent 7566453 Methods for treating melanomas
‌
US Patent 7566770 Humanized collagen antibodies and related methods
‌
US Patent 7566771 Humanised antibodies
‌
US Patent 7569662 Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
‌
US Patent 7572443 Anti-PECAM therapy for metastasis suppression
‌
US Patent 7572886 Death associated proteins, and THAP1 and PAR4 pathways in apoptosis control
‌
US Patent 7572896 Antibodies to oncostatin M receptor
‌
US Patent 7575748 Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
‌
US Patent 7575922 Polypeptide and gene encoding the same
‌
US Patent 7576178 DADD, death activator death domain protein
‌
US Patent 7576191 Tumor suppressor Killin
‌
US Patent 7579160 Methods for the detection of cervical cancer
‌
US Patent 7579445 Reagents and methods for inducing an immune response to prostate specific antigen
‌
US Patent 7582733 Humanized antibodies that recognize beta amyloid peptide
‌
US Patent 7585503 Method for detecting multi-drug resistance
‌
US Patent 7585506 Compositions and methods for the therapy and diagnosis of lung cancer
‌
US Patent 7592145 Pin 1 as a marker for prostate cancer
‌
US Patent 7592430 Antibodies to M-CSF
‌
US Patent 7595149 Methods for cancer detection
‌
US Patent 7597890 Methods and compositions for diagnosing lung cancer
‌
US Patent 7598028 Compositions and methods for detecting and treating prostate disorders
‌
US Patent 7598042 Early prostate cancer antigens (EPCA), polynucleotide sequences encoding them, and their use
‌
US Patent 7598341 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs
‌
US Patent 7601348 Method of examining colon cancer and colon adenoma
‌
US Patent 7604804 Enhancing anti-HIV efficiency through multivalent inhibitors targeting oligomeric gp120
‌
US Patent 7604939 Methods of identifying active BRM expression-promoting HDAC inhibitors
‌
US Patent 7605235 Anti-tissue factor antibodies and compositions
‌
US Patent 7608699 Synthetic nuclear localization signal derived from lentiviral integrase and methods of use thereof
‌
US Patent 7611703 Kidney disease targets and uses thereof
‌
US Patent 7611892 Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
‌
US Patent 7611894 Anti-idiotype antibodies of the human monoclonal antibody SC-1, and their production and use
‌
US Patent 7612035 Inhibition of mitogen-activated protein kinase (MAPK) pathway: a selective therapeutic strategy against melanoma
‌
US Patent 7615372 Antibodies with immune effector activity and that internalize in endosialin-positive cells
‌
US Patent 7618772 Methods and compositions for diagnosing and suppressing metastasis thereof
‌
US Patent 7622253 Classification of patients having diffuse large b-cell lymphoma based upon gene expression
‌
US Patent 7625716 Methods for assessing p19-Arf interactions in cMyc
‌
US Patent 7626011 Antibodies against tumor surface antigens
‌
US Patent 7628989 Methods of inducing an immune response
‌
US Patent 7632635 Method for measuring resistance of a patient HIV-2 to protease inhibitors
‌
US Patent 7632814 HYD1 peptides as anti-cancer agents
‌
US Patent 7632927 Radioimmunoconjugates for targeted alpha therapy
‌
US Patent 7641896 Adjuvant viral particle
‌
US Patent 7641902 Compositions and methods for detecting cancer and for inhibiting metastasis
‌
US Patent 7641905 Methods of inducing an immune response
‌
US Patent 7642050 Method for predicting responsiveness of breast cancer to antiestrogen therapy
‌
US Patent 7645452 RTVP based compositions and methods for the treatment of prostate cancer
‌
US Patent 7645859 Tumour suppressor protein
‌
US Patent 7651687 Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors
‌
US Patent 7655461 Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen
‌
US Patent 7659073 Forms of prostate specific antigens and methods for their detection
‌
US Patent 7662387 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
‌
US Patent 7666391 Breast homing peptides and methods of identifying same using aminopeptidase P
‌
US Patent 7666412 Methods for the treatment of neoplastic disorders with anti-caveolin agents
‌
US Patent 7666581 Methods for preparing compositions comprising heat shock proteins useful for the treatment of cancer and infectious disease
‌
US Patent 7666584 Identification of a pin specific gene and protein (PIN-1) useful as a diagnostic treatment for prostate cancer
‌
US Patent 7666604 Modified soluble T cell receptor
‌
US Patent 7670604 Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
‌
US Patent 7671010 Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
‌
US Patent 7678374 Viral vectors expressing fusion of viral large envelope protein and protein of interest
‌
US Patent 7696307 Function and regulation of ADAMTS-1
‌
US Patent 7696320 Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor
‌
US Patent 7700271 Method of diagnosis and treatment and agents useful for same
‌
US Patent 7700749 Nucleic acid and corresponding protein entitled 205P1B5 useful in treatment and detection of cancer
‌
US Patent 7700751 Humanized antibodies that recognize β-amyloid peptide
‌
US Patent 7704507 Anticancer vaccine and diagnostic methods and reagents
‌
US Patent 7709003 Method of producing an HIV-1 immune response
‌
US Patent 7709004 Method of producing an HIV-1 immune response
‌
US Patent 7714109 Combinations and kits for cancer treatment using selected antibodies to aminophospholipids
‌
US Patent 7714119 AAV vector compositions and methods for enhanced expression of immunoglobulins using the same
‌
US Patent 7723292 Compositions and methods for treating cancer
‌
US Patent 7723484 Anti-EGFR antibodies
‌
US Patent 7723485 Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates
‌
US Patent 7723496 Preventives/remedies for cancer
‌
US Patent 7727526 Use of PTHrP antagonists for treating renal cell carcinoma
‌
US Patent 7728113 Methods of treating arthritic conditions with antibodies to M-CSF
‌
US Patent 7736651 Alpha emitting constructs and uses thereof
‌
US Patent 7736654 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
‌
US Patent 7736846 Methods of assaying for modulators of the inflammatory process using components of the ubiquitin ligation cascade
‌
US Patent 7736848 Cellular targets for treatment of retroviral infection
‌
US Patent 7736856 Method of screening drug with the use of 67 kDa laminin receptor and drug obtained thereby
‌
US Patent 7740846 Inhibitors of angiopoietin-like 4 protein, combinations, and their use
‌
US Patent 7740872 Method of treating cancer cells to create a modified cancer cell that provokes an immunogenic response
‌
US Patent 7741276 Use of interleukin-18 inhibitors to inhibit tumor metastasis
‌
US Patent 7741443 Binding molecules for the treatment of myeloid cell malignancies
‌
US Patent 7744870 ST receptor binding compounds and methods of using the same
‌
US Patent 7749505 Compositions and methods for the therapy and diagnosis of lung cancer
‌
US Patent 7749962 Alpha 5 beta 1 and its ability to regulate the cell survival pathway
‌
US Patent 7750125 Antibodies that bind to the C35 polypeptide
‌
US Patent 7754859 Targeted binding agents directed to PDGFR-alpha and uses thereof
‌
US Patent 7763245 Methods and compositions for targeting polyubiquitin
‌
US Patent 7763252 Methods for the treatment of cellular proliferative disorders
‌
US Patent 7763581 Mutants of trichosanthin with anti-tumor activity and lowered side-effects
‌
US Patent 7767403 Compositions and methods for the diagnosis and treatment of tumor
‌
US Patent 7767406 Method for diagnosing tumors
‌
US Patent 7771953 Methods of diagnosing and treating cancer
‌
US Patent 7771968 Gene upregulated in cancers of the prostate
‌
US Patent 7772367 C-terminal p53 palindromic peptide that induces apoptosis of cells with aberrant p53 and uses thereof
‌
US Patent 7777008 ILT3 binding molecules and uses therefor
‌
US Patent 7777018 CDR-grafted anti-tissue factor antibodies and methods of use thereof
‌
US Patent 7777019 Mutated Anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells
‌
US Patent 7781393 Methods for inhibiting tumor cell growth
‌
US Patent 7781398 Drug comprising synthetic peptide analogs for the treatment of cancer
‌
US Patent 7781569 Antibodies to treat cancer
‌
US Patent 7785801 Identification of surface-associated antigens for tumor diagnosis and therapy
‌
US Patent 7785811 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells
‌
US Patent 7785881 MAGE-C2 antigenic peptides and uses thereof
‌
US Patent 7785903 Variable domain library and uses
‌
US Patent 7786266 Methods for damaging cells using effector function of anti-DSC2 antibody
‌
US Patent 7786279 Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection
‌
US Patent 7790853 Determination of bone-sialoprotein in bodily fluids for oncological problems
‌
US Patent 7790855 KID3 and KID3 antibodies that bind thereto
‌
US Patent 7790856 Humanized antibodies that recognize beta amyloid peptide
‌
US Patent 7790857 Monoclonal antibodies and uses thereof
‌
US Patent 7790866 Cancer-associated gene
‌
US Patent 7794711 Agent for treating chondroma and chondrosarcoma
‌
US Patent 7794713 Compositions and methods for the treatment and prevention of hyperproliferative diseases
‌
US Patent 7795205 Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
‌
US Patent 7795381 Methods and materials for cancer treatment
‌
US Patent 7795391 Protein showing enhanced expression in cancer cells
‌
US Patent 7795417 Oligonucleotides and methods for detection of west nile virus
‌
US Patent 7799518 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
‌
US Patent 7799519 Diagnosing and grading gliomas using a proteomics approach
‌
US Patent 7799896 Methods of inhibiting tumor cell proliferation
‌
US Patent 7799899 Compositions and methods relating to STOP-1
‌
US Patent 7803379 Tumour-specific animal proteins
‌
US Patent 7803916 Gene expressed in prostate cancer
‌
US Patent 7807379 Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker
‌
US Patent 7807621 Anti-invasive and anti-angiogenic compositions
‌
US Patent 7807626 Tumor suppressor protein and nucleotide encoding same
‌
US Patent 7807784 Increased T-cell tumor infiltration by mutant LIGHT
‌
US Patent 7807785 Androgen regulated prostate specific nucleic acids
‌
US Patent 7807788 Chimeric and humanised monoclonal antibodies against Interleukin-13
‌
US Patent 7807792 Tumor antigen based on products of the tumor suppressor gene WT1
‌
US Patent 7807804 Methods and compositions for improving recombinant protein production
‌
US Patent 7811561 MCT-1, a human oncogene
‌
US Patent 7811574 Tumour-specific animal proteins
‌
US Patent 7811774 Reagents and methods for use in cancer diagnosis, classification and therapy
‌
US Patent 7811982 Compounds and methods for treating cancer
‌
US Patent 7811983 Increased T-cell tumor infiltration and eradication of metastases by mutant light
‌
US Patent 7811986 Genes from the 20Q13 amplicon and their uses
‌
US Patent 7812116 Immunogenic peptides
‌
US Patent 7812124 Profiling tumor specific markers for the diagnosis and treatment of neoplastic disease
‌
US Patent 7812128 Gene overexpressed in cancer
‌
US Patent 7815907 Antibodies to insulin-like growth factor I receptor
‌
US Patent 7815914 Methods for the treatment of cellular proliferative disorders
‌
US Patent 7816076 Therapeutic targets in cancer
‌
US Patent 7816087 Gene expressed in prostate cancer and methods of use
‌
US Patent RE41887 Treatment of autoimmune disease
‌
US Patent 7824685 RTVP based compositions and methods for the treatment of prostate cancer
‌
US Patent 7824872 Pharmaceutical agents
‌
US Patent 7825219 Medicament for treating tumours and their metastases
‌
US Patent 7829675 TWEAK receptor
‌
US Patent 7829677 Antibodies that recognize hyperproliferative cells and methods of making and using same
‌
US Patent 7833750 Card-domain containing polypeptides, encoding nucleic acids, and methods of use
‌
US Patent 7834147 Saposin C-DOPS: a novel anti-tumor agent
‌
US Patent 7834149 Card-domain containing polypeptides, encoding nucleic acids, and methods of use
‌
US Patent 7838634 Methods for measuring glycan levels of proteins
‌
US Patent 7842291 Methods and compositions for diagnosing and treating diseases
‌
US Patent 7842461 CD38 as a prognostic indicator in B cell chronic lymphocytic leukemia
‌
US Patent 7842787 Biological products
‌
US Patent 7846653 ASC as a marker for colorectal cancer
‌
US Patent 7846692 HE4 monoclonal antibodies and methods for their use
‌
US Patent 7851144 Compositions and methods for detecting cancer
‌
US Patent 7851212 Immunogenic polypeptides encoded by MAGE minigenes and uses thereof
‌
US Patent 7851455 MN gene and protein
‌
US Patent 7854932 Immunogenic compositions comprising progastrin and uses thereof
‌
US Patent 7855185 MN gene and protein
‌
US Patent 7855271 Compositions and methods for the therapy and diagnosis of breast cancer
‌
US Patent 7858297 Chemokine-binding protein and methods of use
‌
US Patent 7858745 Use of specifically engineered enzymes to enhance the efficacy of prodrugs
‌
US Patent 7858753 Immunoglobulins
‌
US Patent 7858756 Monoclonal antibodies that selectively recognize methamphetamine and methamphetamine like compounds
‌
US Patent 7862812 Methods for decreasing immune response and treating immune conditions
‌
US Patent 7867501 Nucleic acid and amino acid sequences relating to
‌
US Patent 7871763 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas
‌
US Patent 7871779 Molecular identification of
‌
US Patent 7875437 Nucleic acid and amino acid sequences relating to
‌
US Patent 7875438 Nucleic acid and amino acid sequences relating to
‌
US Patent 7875439 Nucleic acid and amino acid sequences relating to
‌
US Patent 7883710 Peptide vaccines against Group A streptococci
‌
US Patent 7887817 Process for preventing protozoal diseases
‌
US Patent 7887818 None
‌
US Patent 7888005 Inhibitors of macromolecular activity
‌
US Patent 7888054 None
‌
US Patent 7888468 Cytotoxic factors for modulating cell death
‌
US Patent 7897329 Method for diagnosing non-small cell lung cancers by tRNA-dihydrouridine synthase activity of
‌
US Patent 7919233 Motif of the beclin protein which interacts with anti-apoptotic members of the Bcl-2 protein family, and uses
‌
US Patent 7947496 Cytotoxicity mediation of cells evidencing surface expression of CD44
‌
US Patent 7951375 Methods of inducing an immune response
‌
US Patent 7960505 Lantibiotics and uses thereof
‌
US Patent 7964200 Methods and compositions for immunizing against
‌
US Patent 7968695 Nucleic acids encoding recombinant 56 and 82 kDa antigens from gametocytes of
Edits on 8 Dec, 2021
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7968695 Nucleic acids encoding recombinant 56 and 82 kDa antigens from gametocytes of
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7964200 Methods and compositions for immunizing against
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7960505 Lantibiotics and uses thereof
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7951375 Methods of inducing an immune response
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7947496 Cytotoxicity mediation of cells evidencing surface expression of CD44
Edits on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7888468 Cytotoxic factors for modulating cell death
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7888054 None
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7888005 Inhibitors of macromolecular activity
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7887818 None
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7887817 Process for preventing protozoal diseases
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7883710 Peptide vaccines against Group A streptococci
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7875438 Nucleic acid and amino acid sequences relating to
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7875437 Nucleic acid and amino acid sequences relating to
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7875439 Nucleic acid and amino acid sequences relating to

Find more people like Larry R. Helms

Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.